Related Experiment Videos
[Evolution of depressive disorders]
1Praticien hospitalier, Hôpital Saint-Louis (AP-HP), 1 av. Claude Vellefaux, 75010 Paris, France. christian.spadone@sls.ap-hop-paris.fr
Presse Medicale (Paris, France : 1983)
|December 22, 2004
Summary
Major depressive disorder has a high recurrence risk, with 50-85% of patients relapsing. Viewing depression as a chronic disease and extending treatment post-remission is crucial for managing relapses and improving patient outcomes.
Area of Science:
- Psychiatry and Mental Health
- Neuroscience
- Epidemiology
Context:
- Major depressive disorder (MDD) is characterized by a significant risk of recurrence, impacting 50-85% of individuals after an initial episode.
- The natural course of MDD is poorly understood due to limited data on untreated cases.
- The recurrent nature and substantial psychosocial impact of MDD lead many to classify it as a chronic disease.
Purpose:
- To highlight the high recurrence rates of major depressive disorder.
- To emphasize the importance of managing depression as a chronic condition.
- To advocate for extended treatment durations to prevent relapse and recurrence.
Summary:
- Depression episodes typically last 6-8 months, followed by a high likelihood of relapse.
- Extended treatment (12+ months post-remission) is recommended to reduce relapse risk, especially for patients with multiple episodes.
- Insufficient treatment, often due to a lack of understanding of MDD's chronic nature, contributes to poor outcomes.
Impact:
- Improved patient outcomes through better-informed, long-term management strategies.
- Reduced healthcare burden associated with recurrent depressive episodes.
- Enhanced patient and practitioner understanding of depression as a chronic, manageable condition.